A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist
The effects of selexipag and its active metabolite ACT-333679 on cardiac repolarization were assessed in a thorough QT study as per International Conference on Harmonisation E14 guidance. In this randomized, double-blind, placebo/positive-controlled, parallel-group study, healthy male and female sub...
Main Authors: | Hoch, Matthias, Darpo, Borje, Remenova, Tatiana, Stoltz, Randall, Zhou, Meijian, Kaufmann, Priska, Bruderer, Shirin, Dingemanse, Jasper |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277127/ |
Similar Items
-
Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
by: Kaufmann, Priska, et al.
Published: (2015) -
Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study
by: Darpo, Borje, et al.
Published: (2014) -
Erratum to: Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study
by: Darpo, Borje, et al.
Published: (2014) -
Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study
by: Carlson, Glenn F., et al.
Published: (2011) -
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
by: Ring, Arne, et al.
Published: (2013)